Screener / SEC EDGAR /CIK 0001468328 /10-K filed Feb 24, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Home Health Care Services

Addus HomeCare Corp ADUS

Compare with peers Embed
SEC comment letters, last 20 years

4 reviews of ADUS's filings by SEC staff

UPLOAD and CORRESP
Reviews 4 latest letter Jul 23, 2015
Questions asked 74 each answered in the company's own letter
No closing letter 2 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 7 UPLOAD
  2. 2. Questions in them 74 numbered comments
  3. 3. Company replies 5 CORRESP
  4. 4. Reviews closed 2 of 4 closing letter

Half the closed reviews took 34 days or less from the first letter to the closing letter.

Form 10-K for the Year Ended December 31, 2014

2015-07-23 to 2015-08-26 · 5 questions · 1 letter from the SEC, 2 from the company
Review closed 2015-08-26
Liquidity and cashAcquisitionsLeasesDebt
Addus Homecare Corporation and Subsidiaries Financial Statements · Consolidated Statements of Cash flows, page F-6
SEC asked (1)
We note that you have reflected borrowings on capital lease obligations in the amount of $4,033,000 as cash flows from financing activities in your statement of cash flows for the year ended December 31, 2014. As capital lease transactions are generally non-cash in nature, please revise to eliminate these transactions from your consolidated statement of cash flows pursuant to the guidance in ASC 230-10-50-3 through
Rest of the question

230 -10-50-5 and include them in your supplemental disclosures of non-cash investing and financing activities. Alternatively, please explain why you do not believe this is required.

ADUS answered
During late 2013 and early 2014, Addus began a build-out for its new corporate headquarters and entered into agreements with various vendors for related property and equipment. Addus independently contracted with the vendors, received the property and equipment and for the majority of the capital leases ($2,896,000 of the $4,033,000) paid the vendors directly. For the $2,896,000 where

Addus paid the vendors directly, upon subsequently executing the capital lease agreements with an unrelated lessor, the lessor reimbursed Addus for the cash paid to the vendors.
Rest of the answer

For the remaining $1,137,000 of the capital leases, the capital lessor paid the vendor directly. As the majority of the capital leases operated like a debt or financing arrangement, as of December 31, 2014, Addus reported the $4,033,000 as cash flows from financing activities in the Company’s Statement of

Cash Flows.

Per ASC 230-10-50-5, for transactions that are part cash and part non-cash, only the cash portion shall be reported in the statement of cash flows. As a result, Addus plans to prospectively adjust its Statement of Cash Flows, beginning with its Quarterly Report on Form 10-Q for the quarter ending September 30, 2015 (the “Q3 10-Q”), to reclassify the $1,137,000, for which its lessor paid the vendors directly, under supplemental disclosures of non-cash investing and financing activities. The Company continues to believe that the $2,896,000 of the capital lease as described above should remain as a financing activity due the flow of the transaction operating like a financing arrangement.

Read in the reply
In its next report

First report after the company's reply of Aug 20, 2015: 10-Q filed Nov 6, 2015 ↗, against the 10-Q filed May 8, 2015 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Notes to Consolidated Financial Statements, pa ge F-7 · Note 2. Discontinued Operations, page F-12
SEC asked (2)
We note from your disclosure on page F-12 that you sold 90% of the Home Health Business in California and Illinois, with the Company retaining 10% ownership in such locations, as part of the transaction in which you sold substantially all of the assets used in your home heath business for cash consideration of $20,000,000 in February 2013.
Rest of the question

We also note that you have reflected the results of such operations as discontinued operations in your financial statements for all periods presented. Given that you retained a 10% interest in the Home Health Business in California and Illinois, please explain in detail how you considered the guidance outlined in ASC 205-20-45-1, which requires that an entity have no significant continuing involvement in the operation of the component after the disposal transaction, in determining that these operations meet the criteria for treatment as discontinued operations in your consolidated financial statements. Also, please explain how you considered the guidance in ASC 205-20-55 in determining that the operations and cash flows of the Home Health Business in California and Illinois were eliminated from ongoing operations and should therefore be accounted for as discontinued operations in your financial statements. As part of your response, please explain the nature and amounts of any continuing cash flows that you receive or incur as a result of your 10% retained interest in the California and Illinois Home Health Business and indicate whether any such cash flows have been determined to be direct or indirect cash flows and your basis for such conclusions.

ADUS answered
In order to classify a sale of a segment under discontinued operations, ASC 205-20-45-1 states that the entity will not have any significant continuing involvement in the operations of the component after the disposal transaction. As part of the sale of the Home Health Business to subsidiaries of LHC Group, Inc., the Company recorded a 10% investment ownership in the California and

Illinois Home Health Business, which is classified on the Consolidated Balance Sheets as Investment in joint venture and valued at $900,000 at December 31, 2014.
Rest of the answer

The management and daily operations of this joint venture is solely the responsibility of affiliates of LHC Group, Inc. The Company does not have involvement in the management, day-to-day or otherwise, of the business and has a small percentage of ownership. As a result, the Company is unable to exert significant influence over the business. The Company believes that it has met the requirements under ASC 205-20-45-1 to consider the sale of its Home Health Business under discontinued operations.

Additionally, in order to classify a sale of a segment under discontinued operations, ASC 205-20-55 requires that operations and cash flows of a disposed component are eliminated from ongoing operations. As described above, the 10% ownership of the Home Health Business in California and Illinois was recorded as an Investment in joint venture. Cash flows from this joint venture would only occur if LHC Group, Inc. declared a dividend on the investment and therefore are eliminated from ongoing operations. Furthermore, to date, the Company has not received a dividend and does not anticipate receiving a dividend in the near future. As a result, the Company also believes any cash flows from this investment would be insignificant. The Company believes it has met the requirements under ASC 205-20-55 to record the sale of its Home Health Business under discontinued operations.

Read in the reply
In its next report

First report after the company's reply of Aug 20, 2015: 10-Q filed Nov 6, 2015 ↗, against the 10-Q filed May 8, 2015 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 4. Acquisitions, page F-13
SEC asked (3)
We note from your disclosure on page F-13, that in connection with the acquisition of Aid & Assist during June 2014, the company recognized a liability of $1,020,000 for a contingent earn-out obligation associated with the potential obligation to pay up to $1,168,000 based on probability-weighted estimates of achievement of certain performance targets.
Rest of the question

We also note that as of December 31, 2014, the Company revalued this liability to $200,000. Please tell us and revise the notes to your financial statements to explain the nature of the changes in facts, circumstances or assumptions that resulted in the decline in this obligation from June 2014 through December 31, 2014. Refer to the disclosure requirements outlined in ASC 805-30-50-4. Also, please explain where the decline in this obligation was reflected in your consolidated statement of operations for the year ended December 31, 2014.

ADUS answered
ASC 205-20-45-1 requires any changes in the range of outcomes (undiscounted) and the reasons for those changes be disclosed for each reporting period after the acquisition date until the entity collects, sells or otherwise loses the right to a contingent consideration asset, or until the entity settles a contingent consideration liability or the liability is cancelled or expires. While the Company disclosed the amount of valuation change, the Company agrees that it should further disclose the reasons for those changes.
Rest of the answer

Beginning with the Q3 10-Q, the

Company will update the language in the acquisition footnote to the following:

As of June 1, 2014, the contingent earn-out obligation was recorded at its fair value of $1,020,000, which was the present value of the Company’s obligation to pay up to $1,168,000 based on probability-weighted estimates of the achievement of certain performance targets, as defined in the earn-out agreement between the parties. As of December 31, 2014, the Company revalued this liability at $200,000. This decline in the fair value of the contingent earn-out obligation reflects the acquisition’s failure to achieve performance targets expected at the date of acquisition for 2014 and the expectation that the acquisition will fail to achieve performance targets in 2015 and 2016. A significant contributing factor to the reduction in performance expectations is attributable to the loss of a key management employee in 2014, which was not anticipated at the time of the acquisition.

Also, please explain where the decline in this obligation was reflected in your consolidated statements of operations for the year ended

December 31, 2014.

Response:

The $820,000 decline in the Aid & Assist contingent earn-out obligation was recorded as revaluation of contingent consideration gain.

However, as described in response to Comment 4 below, the Coordinated Home Health Care LLC contingent earn-out obligation increased by $820,000 and was recorded as a revaluation of contingent consideration loss. As these amounts offset, the net revaluation of contingent consideration is zero and therefore not disclosed on the face of the Statements of Operations.

Read in the reply
In its next report

First report after the company's reply of Aug 20, 2015: 10-Q filed Nov 6, 2015 ↗, against the 10-Q filed May 8, 2015 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 4. Acquisitions, page F-13
SEC asked (4)
In a related matter, please also explain why the contingent earn -out obligation recognized in connection with the Coordinated Home Health Care LLC acquisition of $1,100,000 as of December 1, 2013 increased to $1,920,000 as of December 31, 2014 as disclosed on page F-15.
ADUS answered
ASC 205-20-45-1 requires any changes in the range of outcomes (undiscounted) and the reasons for those changes be disclosed for each reporting period after the acquisition date until the entity collects, sells or otherwise loses the right to a contingent consideration asset, or until the entity settles a contingent consideration liability or the liability is cancelled or expires. While the

Company disclosed the amount of valuation change, the Company agrees that it should further disclose the reasons for those changes.
Rest of the answer

Beginning with the Q3 10-Q, the Company will update the language in the acquisition footnote to the following:

As of December 1, 2013, the contingent earn-out obligation was recorded at its fair value of $1,100,000, which was the present value of the Company’s obligation to pay up to $2,250,000 based on probability-weighted estimates of the achievement of certain performance targets, as defined in the earn-out agreement between the parties. As of December 31, 2014, the Company revalued this liability at $1,920,000. This increase in the fair value of the contingent earn-out obligation reflects the acquisition’s excess achievement of performance targets for the year-ended December 31, 2014 as a result of higher than anticipated rate of conversion to managed care organizations in the State of New Mexico. $1,000,000 of the liability, which was recorded as the current portion at December 31, 2014, was subsequently paid during the second quarter of 2015.

Read in the reply
In its next report

First report after the company's reply of Aug 20, 2015: 10-Q filed Nov 6, 2015 ↗, against the 10-Q filed May 8, 2015 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 8. Long-Term Debt, page F-20
SEC asked (5)
We note from the disclosure on page F-22 and elsewhere in your filing that your credit facility includes covenants that restrict your ability to pay dividends and other distributions. Please revise the notes to your financial statements to disclose the significant terms of these dividend restrictions. Refer to the disclosure requirements outlined in Rule 4-08(e) of Regulation S-X.
ADUS answered
The Company agrees with the SEC’s comment and has included the additional disclosure in all SEC filings beginning with its Quarterly Report on Form 10-Q for the quarter ended June 30, 2015. The Long-Term Debt, Secured Senior Credit Facility disclosure’s last paragraph has been revised to add the language bracketed below:

The credit facility contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes.
Rest of the answer

The credit facility also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum fixed charge coverage ratio, a requirement to stay below a maximum senior leverage ratio and a requirement to stay below a maximum permitted amount of capital expenditures, as well as restrictions on guarantees, indebtedness, liens, distributions, investments and loans, subject to customary carve outs, [a restriction on dividends (unless no default then exists or would occur as a result thereof, the Company is in pro forma compliance with the financial covenants contained in the credit facility after giving effect thereto, and the Company has an excess availability of at least 10% of the revolving credit commitment under the credit facility)], restrictions on the Company’s ability to enter into transactions other than in the ordinary course of business, a restriction on the ability to consummate more than three acquisitions in any calendar year, or for the purchase price of any one acquisition to exceed $2,000,000, in each case without the consent of the lenders, restrictions on mergers, transfers of assets, acquisitions, equipment, subsidiaries and affiliate transactions, subject to customary carve outs, and restrictions on fundamental changes and lines of business.

Read in the reply
In its next report

First report after the company's reply of Aug 20, 2015: 10-Q filed Nov 6, 2015 ↗, against the 10-Q filed May 8, 2015 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: request for more time, Jul 29, 2015, company letter, Aug 25, 2015, closing letter, 2015-08-26

Form S-3

2013-11-21 to 2013-11-27 · 2 questions · 1 letter from the SEC, 1 from the company
No closing letter
General
SEC asked (1)
Please revise to describe the initial transactions by which the selling shareholders acquired the shares they are offering for resale.
ADUS answered
We have revised the Registration Statement to include a general description of the initial transactions by which the selling shareholders acquired the shares they are offering for resale. See page 12 of Amendment No. 1 to the Registration Statement.

Page

The staff is advised that on September 19, 2006, the Company issued: (a) 28,940 shares of its series A preferred stock to Eos Capital Partners III, L.P. in exchange for aggregate consideration of $28,940,000 and (b) 8,310 shares of its series A preferred stock to Eos Partners SBIC III, L.P.
Rest of the answer

in exchange for aggregate consideration of $8,310,000, the proceeds of which were used to fund a portion of the purchase price paid in connection with the Company’s acquisition of Addus HealthCare, Inc. (“Addus HealthCare”). Such shares of series A preferred stock converted into common stock in connection with the Company’s initial public offering consummated on November 2, 2009. The Company issued these securities to these accredited investors in reliance upon Section 4(2) of the

Securities Act of 1933 as a transaction by an issuer not involving a public offering. Each entity had adequate access to information about the Company through its relationship with the Company or through information provided to them.

On September 19, 2006, in connection with the Company’s acquisition of Addus HealthCare, the Company issued shares of its common stock to W. Andrew Wright, III, James A. Wright, Courtney E. Panzer and Addus Term Trust, former stockholders of Addus HealthCare, in exchange for their contribution of shares of Addus HealthCare common stock. Such shares of common stock were issued in reliance upon Section 4(2) of the Securities Act of 1933 as a transaction by an issuer not involving a public offering. Each such person had adequate access to information about the Company through his or her relationship with the Company or through information provided to him or her. The Company was advised by Courtney E. Panzer that she subsequently transferred her shares to the Courtney E. Panzer Living Trust II.

Read in the reply
Exhibits
SEC asked (2)
We note that you will be filing your legal opinion by amendment. Please note that we may have comments upon review.
ADUS answered
Our legal opinion is provided as Exhibit 5.1 to Amendment No. 1 to the Registration Statement.
Read in the reply

Form 10-K for the Fiscal Year Ended December 31, 2011

2012-11-08 to 2012-12-07 · 1 question · 1 letter from the SEC, 2 from the company
Review closed 2012-12-07
Note 1 – Summary of Significant Accounting Policies, page 7 · Allowance for Doubtful Accounts, page 8
SEC asked
Please confirm to us that you will provide qualitative and quantitative information for the changes in your allowance for doubtful accounts required by FASB ASC Topic 954-31050-3 or tell us why you either believe this guidance does not apply to you or you have already complied with this guidance.
Rest of the question

If applicable, please provide us with the text of your proposed future disclosures based on your September 30, 2012 financial statements.

ADUS answered
This letter is being sent in response to the comments of the staff of the Securities and Exchange Commission (the

“Commission”) set forth in your letter dated November 8, 2012. Addus HomeCare Corporation (the “Company”) is in the process of reviewing your comments and, as discussed with the staff of the Commission by telephone today, requests an extension of the time to respond to such comments. The Company will provide a substantive response to your comments by November 30, 2012.
Read in the reply
In its next report

First report after the company's reply of Nov 27, 2012: 10-K filed Mar 28, 2013 ↗, against the 10-K filed Mar 16, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: company letter, Nov 30, 2012, closing letter, 2012-12-07

Form S-1

2009-08-14 to 2009-10-09 · 66 questions · 4 letters from the SEC, 0 from the company
No closing letter
AcquisitionsLiquidity and cashRisk factorsDebtRevenueNon-GAAP measuresExecutive paySegmentsResults discussion (MD&A)Goodwill and impairmentCritical estimatesIncome taxes
SEC letter of Aug 14, 2009 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
General
SEC asked (1)
Prior to effectiveness, please have a Nasdaq representative call the staff to confirm that your securities have been approved for listing.
ADUS answered

No reply letter found.

General
SEC asked (2)
Prior to the effectiveness of the company’s registration statement, please inform us as to whether the amount of compensation allowable or payable to the underwriters have received clearance by the Financial Industry Regulatory Authority.
ADUS answered

No reply letter found.

General
SEC asked (3)
We will process your amendments without price ranges. As the price range you select will affect disclosure in several sections of the filing, we will need sufficient time to process your amendments once a price range is included and the material information now appearing blank throughout the document has been provided.
Rest of the question

Please understand that the effect of the price range on disclosure throughout the document may cause us to raise issues on areas not previously commented on.

ADUS answered

No reply letter found.

General
SEC asked (4)
You indicate that your convertible Series A preferred stock holders, Eos Funds and Freeport Loan Fund, LLC, intend to convert their shares into common stock prior to the completion of this offering. Please clarify whether this is a binding agreement or if the conversion is discretionary.
Rest of the question

For example, we note that footnote seven to the financial statements indicates that automatic or mandatory conversion would occur upon consummation of an IPO “meeting predetermined qualifying thresholds.” It is unclear what these thresholds are and whether this IPO will meet these thresholds.

ADUS answered

No reply letter found.

General
SEC asked (5)
We note that you intend to have a new credit facility to replace your existing credit facility upon completion of this offering. Please clarify whether this entering into the credit facility is a condition of this offering. Also, to the extent that you have an understanding regarding the terms of the credit facility, please disclose the material terms.
ADUS answered

No reply letter found.

Summary Historical and Pro Forma Consolidated Financial and Other Data, page 7 and · Selected Historical Consolidated Financial and Other Data, page 32
SEC asked (6)
We note your use of non-GAAP financial measure “adjusted EBITDA” which excludes stock based compensation and several other recurring items. It appears that you have eliminated recurring items to smooth earnings. As such, it appears that this non-GAAP financial measure is not in compliance with Item 10(e) of Regulation S-K.
Rest of the question

Your current disclosures do not demonstrate the usefulness of these measures and how they are used to evaluate performance considering that several of the items appear to be recurring in your ongoing operations. Accordingly, please remove the presentation of this measure or tell us how your presentation complies with Item 10(e) of Regulation S-K. Refer to "Frequently asked Questions Regarding the Use of Non-GAAP Financial Measures" as issued by the Commission and Item 10(e) of Regulation S-K for detailed guidance.

ADUS answered

No reply letter found.

Risk Factors, page 13
SEC asked (7)
Please remove the reference to “other risks not currently known to us or that we currently consider immaterial.” All material risks should be described in this section. If risks are not deemed material, then they should not be referenced.
ADUS answered

No reply letter found.

Risk Factors, page 13
SEC asked (8)
Please revise to clarify the term “prospective pay services” used in the fourth risk factor on page 18.
ADUS answered

No reply letter found.

Operations, page 43 · Liquidity and Capital Resources, page 64
SEC asked (9)
We note your disclosure that your primary sources of liquidity are cash from operations and borrowings under your credit facility. Considering (i) your cash used from operations for the period ended March 31, 2009 of approximately $1.1 million, (ii) your available borrowings under your credit facility of $3.6 million, (iii) your current maturities of long-term debt of $7.1 million and (iv) recent delays in the
Rest of the question

collection of accounts receivable (as noted in your disclosures on pages 14 and 46), please provide a robust discussion of how you plan to fund operations and satisfy your obligations for the for the next twelve months.

ADUS answered

No reply letter found.

Operations, page 43 · Liquidity and Capital Resources, page 64
SEC asked (10)
Please revise your Liquidity and Capital Resources section on page 64 to address how your 11 acquisitions over the past three years were funded.
ADUS answered

No reply letter found.

Outstanding Accounts Receivable, page 67
SEC asked (11)
Considering the significance of your third party payors, please expand your disclosures to include in a comparative tabular format, the payor mix concentrations and related aging of accounts receivable. At a minimum, the disclosure should indicate the past due amounts and a breakdown by payor classification (i.e. state, local and other government programs, Medicare, Medicaid, commercial, and private duty).
Rest of the question

We would expect state, local, and other government programs to be separately classified from any other grouping. If your billing system does not have the capacity to provide such an aging schedule of your receivables by payor classification, disclose that fact and clarify how this affects your ability to estimate your allowance for bad debts.

ADUS answered

No reply letter found.

Outstanding Accounts Receivable, page 67
SEC asked (12)
We note that you have recorded an allowance for doubtful accounts of 4.9%, 5.2% and 4.5%, for the periods ended March 31, 2009, December 31, 2008 and December 31, 2007, respectively. Please (i) state the steps you take in collecting accounts receivable, (ii) disclose your policy with respect to determining when a receivable is recorded as bad debt and when a write-off is recorded, and (iii) clarify the threshold
Rest of the question

(amount and age) for account balance write-offs. If applicable tell us, both qualitatively and quantitatively, the factors that led to changes in accounting estimates related to individual account write-offs.

ADUS answered

No reply letter found.

Critical Accounting Policies and Estimates · Revenue Recognition, page 70
SEC asked (13)
In regards to your home health segment revenues for each period presented, please quantify and disclose the amount of changes in estimates of prior period net PPS adjustments that you recorded during the current period.
Rest of the question

For example for 2008, this amount would represent the difference between the RAP recorded and amortized and the net PPS adjustments for services provided in 2007 and the settlement amount that was recorded during 2008. In addition, please discuss how your estimates of third-party payer revenue affect your financial statements and how any changes therein could also affect the financial statements.

ADUS answered

No reply letter found.

Accounts Receivable and Allowance for Doubtful Accounts, page 70
SEC asked (14)
We note your disclosure that your credit risk is limited due to the significance of Medicare and state agency payors. Considering that approximately 69% of your 2008 revenues are generated by Medicare and state agency payors (as disclosed on page 13) and that each of those payors are proposing cuts to their budgets, please tell us how that affects your credit risk and your ability to collect outstanding balances.
Rest of the question

Revise your disclosures as appropriate.

ADUS answered

No reply letter found.

Our Business, page 74
SEC asked (15)
Please revise to discuss your efforts to integrate your acquisitions into your business.
ADUS answered

No reply letter found.

Our Business, page 74
SEC asked (16)
Throughout the Prospectus Summary and the Business sections you refer to many statistics about your industry by USAA, NAHC, Georgetown University, AARP, etc. Please cite to specific reports, including the title, date, and author. Also, please indicate where this information may be obtained by the public.
ADUS answered

No reply letter found.

Our Business, page 74
SEC asked (17)
Please state for each of the last three fiscal years the amount or percentage of total revenue contributed by any class of similar services (i.e. in-home personal care and assistance, skilled nursing, etc.) which accounted for 10% or more of consolidates revenue in any of the last three fiscal years. See Item 101(c)(1)(i) of Regulation S-K.
ADUS answered

No reply letter found.

Our Business, page 74
SEC asked (18)
Please revise to clearly describe and explain how the “integrated service delivery model,” see page 74, operates.
ADUS answered

No reply letter found.

Our Business, page 74
SEC asked (19)
On page 75, you reference the rapidly growing private market. Please revise to define the “private market” and explain how it differs from your “private duty”
ADUS answered

No reply letter found.

Our Business, page 74
SEC asked (20)
Please revise to provide a definition or description of “homecare aides” on page 87 and whether they work in both of your divisions. This description should include a general discussion of the education, certification, and/or licensure requirements of your homecare aides. Similarly, please discuss the training, if any, provided to your employees.
ADUS answered

No reply letter found.

Executive Compensation, page 94
SEC asked (21)
Please revise to identify the source of your “market data” and “general industry survey” that you use to establish an initial range of overall compensation, as describe on page 96. We also note the reference to using this information to establish a targeted compensation range and that you seek to compensate your executives “near the mean for similar officers of companies with gross revenues similar” to yours.
Rest of the question

This appears to be benchmarking. Therefore, please identify the specific companies used in this report(s). See Item 402(b)(2)(xiv) of

ADUS answered

No reply letter found.

Executive Compensation, page 94
SEC asked (22)
Provide a more detailed discussion of how you determine the base salary for your named executives. To the extent the specific performance areas referred to on page 97 were considered in determining whether a merit increase in base salary was warranted, provide a more detailed discussion of the specific performance areas and factors considered. In addition, discuss the specific weight for each performance area.
Rest of the question

Also, disclose the specific guidelines, the failure of which would result in Mr. Wright not receiving the 5% increase set forth in the employment agreement. Lastly, we note the increase in Mr. Diamond’s base salary due to an employment agreement. Please disclose the terms of the employment agreement, as they relate to base salary. See Item 402(b)(1)(v) of

ADUS answered

No reply letter found.

Certain Relationships and Related Party Transactions, page 114
SEC asked (23)
Please revise to provide disclose the terms of the management consulting agreement that will result in Eos Management earning its one-time advisory fee in connection with this offering.
ADUS answered

No reply letter found.

Certain Relationships and Related Party Transactions, page 114
SEC asked (24)
Please revise your description of the formation of Addus Holdings and the acquisition of Addus Heathcare, Inc. on page 112 to clarify that Addus Holdings is Addus Homecare Corporation and Addus Healthcare, Inc. is its subsidiary. Also, please clarify the purchase price for Addus Healthcare, Inc. and how the Contingent Payment Agreement factored into the acquisition.
ADUS answered

No reply letter found.

Description of Capital Stock, page 119
SEC asked (25)
We note your statement that “All outstanding shares of common stock are fully paid and nonassessable, and the shares of common stock to be issued in this offering will be, fully paid and nonassessable.” The statement that these shares are “fully paid and nonassessable” is a legal conclusion that the company is not qualified to make.
Rest of the question

Either attribute this statement to counsel and file counsel’s consent to be named in this section, or delete your statement.

ADUS answered

No reply letter found.

Addus Homecare Corporation · Audited Consolidated Financial Statements
SEC asked (26)
Please note the financial statement updating requirements of Rule 3-12 of Regulation S-X and provide updated consents with any amendment. Notes to Consolidated Financial Statements 1. Significant Accounting Policies
ADUS answered

No reply letter found.

Basis of Presentation, page F-10
SEC asked (27)
We note from your disclosure on page 112 that Addus Holdings was formed in July 2006 to acquire Addus HealthCare. Please tell us about the ownership of Addus Holdings prior to the merger with Addus HealthCare. In your response, clarify the level of common ownership, if any, between both entities prior to the merger.
ADUS answered

No reply letter found.

Basis of Presentation, page F-10
SEC asked (28)
We note from your disclosure on page 112 that as part of the acquisition transaction, Mark S. Heaney and W. Andrew Wright II and his family exchanged shares of common stock of Addus Healthcare for shares of Addus Holdings valued at $528,500 and $8,909,000, respectively. Tell us how you determined the fair value of the shares of Addus Healthcare that were exchanged. 2. Acquisitions, page F-17
ADUS answered

No reply letter found.

Basis of Presentation, page F-10
SEC asked (29)
We note from your disclosure that for all your acquisitions during 2007 and 2008, you acquired certain assets of agencies and recorded goodwill and certain intangible assets. Considering you acquired only certain assets, tell us how the recognition of goodwill is appropriate.
Rest of the question

Please tell us and disclose the percentage of equity interests, if any, acquired and the primary reasons for the acquisitions; include a detailed discussion of the factors that contributed to the purchase price. In your response, please provide us with your analysis of Article 11-01(d) of Regulation S-X in concluding that the 2007 and 2008 acquisitions were business acquisitions instead of the acquisition of assets. 9. Stock Options, page F-28

ADUS answered

No reply letter found.

Basis of Presentation, page F-10
SEC asked (30)
We note that you have used the simplified method to estimate the expected life of your stock options. Considering that your options generally vest over a 5 year period and expire in 10 years, it appears that the expected life of your options is inconsistent with your disclosure on page F-30 (i.e. estimated useful lives of 3-5 years). Refer to SAB 107 for further guidance. Please revise or advise.
ADUS answered

No reply letter found.

Basis of Presentation, page F-10
SEC asked (31)
We note your exercise price of $100 and $110, for options granted in 2006, 2007 and 2008. Considering that you do not have an active market for your shares, please provide a detailed discussion of how you determined the fair market value for your shares for each reporting period and revise your disclosures as appropriate.
ADUS answered

No reply letter found.

Basis of Presentation, page F-10
SEC asked (32)
We note your disclosure that you have not estimated forfeitures for your stock option grants based on your expectations. Considering that 4,164 and 8,246 options were forfeited in 2007 and 2008, respectively, please tell us the factors used by management in determining the amount of forfeitures related to each option grant and revise your disclosures as appropriate.
Rest of the question

Refer to paragraph 80 of SFAS 123(R) for further guidance.

ADUS answered

No reply letter found.

Basis of Presentation, page F-10
SEC asked (33)
It appears that you have not provided the minimum disclosure requirements for share-based payments (i.e. required disclosures for each period an income statement is presented including 2006, weighted average grant-date fair value of options, recognized tax benefit related to compensation costs, etc.).
Rest of the question

Refer to paragraph A240 of SFAS 123(R) for further guidance on the minimum required disclosures and revise your disclosures accordingly.

ADUS answered

No reply letter found.

Unaudited Condensed Consolidated Financial Statements for the Period Ended March 31, 2009
SEC asked (34)
Please revise your interim financial statements to conform to any changes made in the annual financial statements as a result of our comments above.
ADUS answered

No reply letter found.

Other Regulatory
SEC asked (35)
We note you provided pre-acquisition financial statements for several acquisitions during 2007 (F-53 – F-84). Please tell us why these financial statements are included in your registration statement, including your underlying calculations for determining significance (Refer to Article 3-05 of Regulation S-X).
Rest of the question

In addition, provide your basis for exclusion of pre-acquisition financial statements for other acquisitions that were consummated during 2007 and 2008.

ADUS answered

No reply letter found.

Part II · Item 16. Exhibits and Financial Statement Schedules, page II-3
SEC asked (36)
We note that many of your exhibits have not been filed. Please note that we review, and frequently comment upon, these agreements. Accordingly, in order to facilitate your review, please ensure that these exhibits are filed as soon as practicable.
ADUS answered

No reply letter found.

Part II · Item 16. Exhibits and Financial Statement Schedules, page II-3
SEC asked (37)
We note that you have omitted most of the annexes, exhibits, and schedules to the credit agreement and its amendments filed as Exhibits 10.8, 10.8(a), 10.8(b), 10.8(c), 10.8(d), 10.8(e), 10.8(f), 10.8(g). Please file the exhibits in their entirety.
ADUS answered

No reply letter found.

Part II · Item 16. Exhibits and Financial Statement Schedules, page II-3
SEC asked (38)
Please advise us whether any of your agreements with state and local governments to provide services are material agreements subject to Item 601 of Regulation S-K. We note that a significant amount of your business is derived from contracts with state and local authorities in Illinois, Nevada, California, and Washington.
Rest of the question

Closing Comments As appropriate, please amend your registration statement in response to these comments. You may wish to provide us with marked copies of the amendment to expedite our review. Please furnish a cover letter with your amendment that keys your responses to our comments and provides any requested supplemental information. Detailed cover letters greatly facilitate our review. Please understand that we may have additional comments after reviewing your amendment and responses to our comments.

ADUS answered

No reply letter found.

SEC letter of Sep 11, 2009 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
Summary Historical and Pro Forma Consolidated Financial and Other Data, page 7 and · Selected Historical Consolidated Financial and Other Data, page 33
SEC asked (1)
We have reviewed your response to comment six of our letter dated August 14, 2009, noting you consider Adjusted EBITDA to determine compliance with your debt covenants. Your calculation of Adjusted EBITDA, as presented, is not consistent with the calculation required by your debt covenants.
Rest of the question

Please revise your disclosure to address the following items or remove your presentation of Adjusted EBITDA from your registration statement: • Please provide the Adjusted EBITDA figure calculated consistent with your debt covenants, • As Adjusted EBITDA is used to measure compliance with your debt covenants, it is considered a liquidity measure and should be reconciled to cash flow from operations, • Disclose the materiality of the debt agreement and the covenants on your financial condition, • Disclose the amount or limit required for compliance with your covenant, • Disclose the actual or reasonably likely effects of compliance or noncompliance with the covenant on the company's financial condition and liquidity.

ADUS answered

No reply letter found.

Summary Historical and Pro Forma Consolidated Financial and Other Data, page 7 and · Selected Historical Consolidated Financial and Other Data, page 33
SEC asked (2)
We note your response to comment six of our letter dated August 14, 2009 and revised disclosure states that you believe you are able to demonstrate the usefulness of Adjusted EBITDA, consistent with the requirements of Question 8 of the Commission’s FAQ Regarding the Use of Non-GAAP Financial Measures.
Rest of the question

In order to enhance an investor’s understanding, please revise your disclosure to provide a detailed discussion of the following: • The manner in which management uses this measure to conduct or evaluate its business, • The economic substance behind management's decision to use this measure, • The substantive reasons why management believes this measure provides useful information to investors. In the alternative, you may remove the presentation of this measure from your registration statement.

ADUS answered

No reply letter found.

Risk Factors, page 13
SEC asked (3)
In the first paragraph on page 16, you indicate that proposed Centers of Medicare and Medicaid Services regulations will “result in an overall market basket reduction.” Please revise to clarify what is a “market basket reduction” and how it impacts your reimbursement rate or profitability. We note similar disclosures are located on pages 47 and 84.
ADUS answered

No reply letter found.

Risk Factors, page 13
SEC asked (4)
Similarly, you indicate on page 16 that the “proposed update” will be reduced by 2% if certain quality data is not submitted. Please clarify what you mean by “required quality data.” Also, please discuss the risk that this potential reduction would apply to your business.
ADUS answered

No reply letter found.

Operations, page 44 · Liquidity and Capital Resources, page 65
SEC asked (5)
We have reviewed your response to comment nine of our letter dated August 14, 2009, noting that you are anticipating a new credit facility to fund your working capital needs for the next 12 months. Considering (i) your existing cash on hand of $0.9 million, (ii) your cash used from operations for the period ended June 30, 2009 of approximately $4.8 million, (iii) your available borrowings under your credit facility
Rest of the question

of $1.2 million, and (iv) your current maturities of long-term debt of $10.1 million, please expand your discussion of liquidity to clarify how you plan to fund your working capital needs if you are unable to enter into this new credit facility or additional funding becomes unavailable (i.e. Eos Funds, expanded existing credit facility, etc.).

ADUS answered

No reply letter found.

Operations, page 44 · Liquidity and Capital Resources, page 65
SEC asked (6)
We note your response to comment 10 of our letter dated August 14, 2009 that you funded your acquisitions in the past three years with available cash, by issuing notes, and borrowing from your credit agreements. Please revise your Liquidity and Capital Resources section to address how you intend to fund any new acquisitions or expansion into new geographic regions in the next 12 months.
Rest of the question

To the extent acquisitions may be limited due to any financial constraints, provide sufficient disclosure both here and in the risk factors section.

ADUS answered

No reply letter found.

Outstanding Accounts Receivable, page 68
SEC asked (7)
We have reviewed your response to comment 12 of our letter dated August 14, 2009, noting that you did not fully address our comment, thus we are reissuing our comment. Please tell us (i) the amount of receivables that are due to ongoing disputes with specific payors, (ii) at what aging period an allowance for doubtful accounts is recorded (e.g.
Rest of the question

after 90 days, after 180 days, etc.) and when a write-off is recorded (e.g. after 180 days, after 365 days, etc.), and (iii) clarify the threshold (amount and age) for account balance write-offs.

ADUS answered

No reply letter found.

Outstanding Accounts Receivable, page 68
SEC asked (8)
In connection with the comment above, we note that your accounts receivable increased for each of the aging buckets. As you estimate your allowance for doubtful accounts primarily on receivable aging trends and your allowance for doubtful accounts (as a percentage of gross accounts receivable) remained consistent with the prior period, please tell us both qualitatively and quantitatively, the factors that led to
Rest of the question

changes in accounting estimates related to your allowance for doubtful accounts.

ADUS answered

No reply letter found.

Our Business, page 77
SEC asked (9)
We note your response to comment 15 of our letter dated August 14, 2009, and we reissue it. Please revise your disclosure to indicate to what extent your recent acquisitions retain features of their previous identity, structure, and operation. Your revisions on page 82 seem to indicate that some administrative functions are centralized as soon as possible, but provide few details otherwise.
ADUS answered

No reply letter found.

Executive Compensation, page 98
SEC asked (10)
We note your response to comment 21 of our letter dated August 14, 2009, and we reissue the comment in part. Please revise to disclose in greater detail which surveys were used to set your salary guidelines for “similarly situated companies.” For example, you disclose “industry” and “geographic location” were used as categories, but you never mention which industries or geographic regions were covered by the
Rest of the question

surveys. In addition, to the extent the companies that comprised the surveys that were used to benchmark compensation were known by you, please identify the companies that comprised the surveys. To the extent the identities of the companies that comprised the surveys were not known by you, please provide clear disclosure in this section.

ADUS answered

No reply letter found.

Certain Relationships and Related Party Transactions, page 117
SEC asked (11)
Please revise to clarify whether the “termination agreement” as described in the second to last paragraph on page 118 will result in a separate termination fee in addition to the $1.5 million due to Eos Funds as a result of the consent fee agreement. Addus Homecare Corporation Audited Consolidated Financial Statements Notes to Consolidated Financial Statements 9. Stock Options, page F-28
ADUS answered

No reply letter found.

Certain Relationships and Related Party Transactions, page 117
SEC asked (12)
We have reviewed your response to comment 30 of our letter dated August 14, 2009; however, it appears that your expected life is inconsistent with the simplified method specified in SAB 107. Based on your response it appears that your stock grant with a 12-month vesting period and stock grants with a 5-year vesting period should be 5.5 years and 6.5 years, respectively. Please revise.
Rest of the question

Consequently, please revise your other assumptions to be consistent with the expected term of the options (e.g. risk-free discount rate, weighted average fair value etc.). Accordingly, revise your financial statements and disclosures as appropriate or demonstrate to us how the changes in the assumptions did not have any material impact on your recorded compensation expense.

ADUS answered

No reply letter found.

Other Regulatory
SEC asked (13)
We have reviewed your response to our prior comment 35, noting your analysis applying SAB 80. Please address the following: • Please tell us why you combined SuCasa Personal Care, LLC with Desert PCA of Nevada, LLC and Vegas Valley Personal Care, LLC with Greater Vegas Personal Care, LLC • Please explain to us the basis for selecting the financial statements presented while excluding the financial statements of
Rest of the question

Silver State in your filing. • Reconcile the purchase price paid for the acquisitions in 2007 and 2008 disclosed in your analysis (Exhibit A) to the disclosures in page F-9, F-17 and F-18.

ADUS answered

No reply letter found.

Part II · Item 16. Exhibits and Financial Statement Schedules, page II-3
SEC asked (14)
We reissue comment 37 of our letter dated August 14, 2009. Please file exhibits 10.8, 10.8(a), 10.8(b), 10.8(e), and 10.8(f) in their entirety. This amendment only included certain portions of the schedules, attachments and exhibits. Closing Comments As appropriate, please amend your registration statement in response to these comments.
Rest of the question

You may wish to provide us with marked copies of the amendment to expedite our review. Please furnish a cover letter with your amendment that keys your responses to our comments and provides any requested supplemental information. Detailed cover letters greatly facilitate our review. Please understand that we may have additional comments after reviewing your amendment and responses to our comments. Any questions regarding the accounting comme nts may be directed to Bill Kearns at (202) 551-3727 or Raj Rajan at (202) 551-3388. Questions on other disclosure issues may be directed to Edwin S. Kim at (202) 551-3297 or Pamela Howell, Special Counsel, at (202) 551-3357. S i n c e r e l y , John Reynolds Assistant Director cc: Dominick DeChiara, Esq.

ADUS answered

No reply letter found.

SEC letter of Sep 28, 2009 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
Operations · Outstanding Accounts Receivable, page 67
SEC asked (1)
We have reviewed your response to our prior comment eight, noting that your Home and Community segment had an increase in accounts receivable aging of $2.5 million due to the conversion process. Considering (i) the substantial increase in each aging bucket, (ii) your accounts receivable increased approximately $14.6 Million from December 31, 2008 to June 30, 2009, and (iii) your allowance for doubtful accounts (as a
Rest of the question

percentage of gross accounts receivable) remained consistent with prior periods, tell us how you allocated your historical collection rates to each of the aging buckets in order to determine your allowance for doubtful accounts. Further, if certain payors are excluded from your historical collection analysis, please tell us the factors that affect the allowance for doubtful accounts related to those certain payors.

ADUS answered

No reply letter found.

Certain Relationships and Related Party Transactions, page 116
SEC asked (2)
We note that Mr. Wright will resign as Chairman following completion of this offering. Please quantify the benefits to be received as a result of the separation and general release agreement. Closing Comments As appropriate, please amend your registration statement in response to these comments. You may wish to provide us with marked copies of the amendment to expedite our review.
Rest of the question

Please furnish a cover letter with your amendment that keys your responses to our comments and provides any requested supplemental information. Detailed cover letters greatly facilitate our review. Please understand that we may have additional comments after reviewing your amendment and responses to our comments. Any questions regarding the accounting comme nts may be directed to Bill Kearns at (202) 551-3727 or Raj Rajan at (202) 551-3388. Questions on other disclosure issues may be directed to Edwin S. Kim at (202) 551-3297 or Pamela Howell, Special Counsel, at (202) 551-3357. S i n c e r e l y , John Reynolds Assistant Director cc: Dominick DeChiara, Esq.

ADUS answered

No reply letter found.

SEC letter of Oct 9, 2009 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
General
SEC asked (1)
It appears that the maximum aggregate offering price calculated using the maximum offering price and the amount of securities being registered, including the over-allotment, results in a maximum aggregate offering price of $74.75 million, rather than the $69 million included in the fee table in the initial registration statement. Please revise the fee table to reflect the maximum aggregate offering price.
Rest of the question

We direct your attention to Rule 457(o) of Regulation C.

ADUS answered

No reply letter found.

Summary Historical and Pro Forma Consolidated Financial and other Data, page 7 and · Unaudited Pro Forma Financial Information, page 38
SEC asked (2)
We note your disclosure that your pro forma statements of income for the fiscal year ended December 31, 2008 and the six months ended June 30, 2009 gives effect to your borrowings under your new credit facility of $18.8 million and repayment of existing credit facility of $58.8 million.
Rest of the question

However your pro forma consolidated balance sheet data as of June 30, 2009 give effect to borrowings under the new credit facility of $26.6 million and repayment of existing facility of $60.1 million. While there appears to be some disclosure related to the difference in Note 4, a clear reconciliation of the difference would aid an investor in understanding this difference. Please revise to clarify the factors that attribute to this difference.

ADUS answered

No reply letter found.

Summary Historical and Pro Forma Consolidated Financial and other Data, page 7 and · Unaudited Pro Forma Financial Information, page 38
SEC asked (3)
We note your disclosure that the pro forma financial statements include the elimination of fees payable to your affiliate Eos Funds under the management consulting agreement. Please (i) reconcile this disclosure with your disclosures on page 42, (ii) show us where these fees are provided for in your pro forma adjustments, (iii) disclose the nature of the management fees and the services provided and (iv) demonstrate
Rest of the question

to us how the elimination of these fees are appropriate under Article 11 of Regulation S-X.

ADUS answered

No reply letter found.

Unaudited Pro Forma Consolidated Balance Sheet as of June 30, 2009, page 39
SEC asked (4)
We note the adjustments you made to additional paid in capital of $82,007 and elimination of retained earnings of $7,913. Please revise your disclosures on page 42 to clarify how these adjustments were determined (i.e. a reconciliation).
ADUS answered

No reply letter found.

Notes to Unaudited Pro Forma Financial Information, page 42
SEC asked (5)
Please revise to disclose in detail the adjustments relating to elimination of general and administrative expenses $(350) and $(176), respectively, in the unaudited pro forma consolidated statements of income for the calendar year ended December 31, 2008 on page 40 and the unaudited pro forma consolidated statements of income for the six months ended June 30, 2009 on page 41.
ADUS answered

No reply letter found.

Notes to Unaudited Pro Forma Financial Information, page 42
SEC asked (6)
We note your disclosure in Note 1(c) that you have recorded approximately $10.8 Million of goodwill relating to the contingent payment. However, the contingent agreement as disclosed on page 121, indicate the contingent payment should be $10 Million, with any additional amount attributed to interest. Please reconcile this apparent inconsistency and revise your disclosures as appropriate.
ADUS answered

No reply letter found.

Notes to Unaudited Pro Forma Financial Information, page 42
SEC asked (7)
We note various adjustments totaling $5,341 (Note 3) which appear to be charged to additional paid-in capital. Please tell us why you believe such a charge is appropriate and why such amounts should not be charged to retained earnings.
ADUS answered

No reply letter found.

Notes to Unaudited Pro Forma Financial Information, page 42
SEC asked (8)
We note various adjustments to interest expense under Note 4. Please provide us your analysis supporting such amounts.
ADUS answered

No reply letter found.

Notes to Unaudited Pro Forma Financial Information, page 42
SEC asked (9)
Please disclose the interest rate of the new credit facility and, if applicable, how the interest rate can vary. Further, please disclose the effect on income of a 1/8 percent variance in interest rates.
ADUS answered

No reply letter found.

Notes to Unaudited Pro Forma Financial Information, page 42
SEC asked (10)
It does not appear that the elimination of your interest rate agreement in Note 4(iii) is directly attributable to the transaction nor is it factually supportable. Please note that infrequent or non-recurring charges should not be eliminated in the preparation of your pro forma income statements. Refer to Article 11 of Regulation S-X for further guidance. Please revise or advise.
ADUS answered

No reply letter found.

Notes to Unaudited Pro Forma Financial Information, page 42
SEC asked (11)
We note your pro forma adjustments to income tax expense to the unaudited pro forma consolidated statements of income for the year ended December 31, 2008 and for the six-months ended June 30, 2009. Considering that your adjustments increase your effective income tax rate for each period, please disclose the facts and circumstances in a sufficiently detailed manner to clearly explain the assumptions involved in
Rest of the question

arriving at your pro forma adjustments.

ADUS answered

No reply letter found.

Principal Stockholders, page 124
SEC asked (12)
We note that the beneficial ownership table does not include common stock or options that will be issued immediately following the date of the prospectus. Please explain why such stock and options are not reflected in the beneficial ownership table pursuant to Item 403 of Regulation S-K, which refers to Rule 13d-3(d)(1) of the Exchange Act.
Rest of the question

Closing Comments As appropriate, please amend your registration statement in response to these comments. You may wish to provide us with marked copies of the amendment to expedite our review. Please furnish a cover letter with your amendment that keys your responses to our comments and provides any requested supplemental information. Detailed cover letters greatly facilitate our review. Please understand that we may have additional comments after reviewing your amendment and responses to our comments. Any questions regarding the accounting comme nts may be directed to Bill Kearns at (202) 551-3727 or Raj Rajan at (202) 551-3388. Questions on other disclosure issues may be directed to Edwin S. Kim at (202) 551-3297 or Pamela Howell, Special Counsel, at (202) 551-3357. S i n c e r e l y , John Reynolds Assistant Director cc: Dominick DeChiara, Esq.

ADUS answered

No reply letter found.

Letters without questions

Other letters

UPLOAD and CORRESP
4 other letters: notices that a filing will not be reviewed, requests to declare a registration effective, and the like

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 19 letters filed since 2009-08-14. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ADUS/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.